Skip to main content

Re: Prevalence and Prognosis of Low-volume, Oligorecurrent, Hormone-sensitive Prostate Cancer Amenable to Lesion Ablative Therapy

Division: 
Citation: 

Aminsharifi, A, and Polascik, TJ. "Re: Prevalence and Prognosis of Low-volume, Oligorecurrent, Hormone-sensitive Prostate Cancer Amenable to Lesion Ablative Therapy." European Urology 74, no. 2 (August 2018): 234-235.

Published Date: 
Wednesday, August 1, 2018
Published In: 
European Urology